Your Location:
Home >
Browse articles >
Single-cell transcriptomic dissection of the cellular and molecular events underlying the triclosan-induced liver fibrosis in mice
RESEARCH | Updated:2024-01-23
    • Single-cell transcriptomic dissection of the cellular and molecular events underlying the triclosan-induced liver fibrosis in mice

    • “On January 23, 2024, a team of experts led by Yun-Meng Bai, Ling-Yun Dai, Qing-Shan Geng, Ji-Gang Wang from the School of Department of Nephrologypublished an article in the MMR, introduces its research progress in the field of triclosan-induced liver fibrosis. The team established a single-cell atlas of TCS-exposed mouse livers, revealing key cellular and molecular mechanisms driving hepatotoxicity, which provides solutions to solve environmental pollutant-related liver disease problems.”
    • Yun-Meng Bai , Fan Yang , Piao Luo , Lu-Lin Xie , Jun-Hui Chen , Yu-Dong Guan , Hong-Chao Zhou , Teng-Fei Xu , Hui-Wen Hao , Bing Chen , Jia-Hui Zhao , Cai-Ling Liang , Ling-Yun Dai , Qing-Shan Geng , Ji-Gang Wang
    • Military Medical Research Vol. 10, Issue 5, Pages: 599-619(2023)
    • DOI: 10.1186/s40779-023-00441-3     

      CLC:

    Scan QR Code

  •  
  •  
  • AI Introduction

  • Full Text(HTML)

  • Figs( 7 ) Tabs( 0 )

  • References

  • Publication Info

  • Metrics

72

Views

48

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies
Immune microenvironment dynamics in pregnant patients with concomitant autoimmune diseases: mechanisms, challenges, and clinical significance
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation
Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients

Related Author

No data

Related Institution

No data